Phase 2A Study of GM 608 in Mild to Moderate Parkinson Disease

NCT01850381 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: GM608
DRUG: Placebo Comparator

Sponsor

Genervon Biopharmaceuticals, LLC

Collaborators

[object Object]